Onglyza, a diabetes drug, may cause cancer or heart failure. Solberg Stewart Miller is reviewing potential Onglyza lawsuits for individuals throughout the United States who have been diagnosed with pancreatic cancer or heart failure that may have been caused by the popular type 2 diabetes drug—Onglyza.
Recent studies have suggested that side effects of Onglyza may increase the risk of chronic pancreatitis, which may cause some users to develop pancreatic cancer. Other research has also indicated that there may be a link between Onglyza and heart failure.
It is possible that the drug manufacturers may have withheld important information about the risk of health problems from Onglyza. As a result, financial compensation may be available through a product liability lawsuit for individuals diagnosed with pancreatic cancer or heart failure;
Solberg Stewart Miller is a law firm that brings claims against drug manufacturers who market “dangerous drugs”. Our law firm does not represent the manufacturers of Onglyza but rather is investigating potential lawsuits against Onglyza in North Dakota and Minnesota as well as other states.
At Solberg Stewart Miller, in bad drug cases, we charge no fees or expenses unless our clients make a recovery. For further information from North Dakota and Minnesota attorneys investigating the diabetes drug, Onglyza, contact Mike Miller at email@example.com or call 1.877.237.3166 (toll free) or 237.3166 (Fargo).